Giuseppe Ciaramella
President chez BEAM THERAPEUTICS INC.
Fortune : 6 M $ au 31/03/2024
Profil
Actuellement, Giuseppe Ciaramella occupe le poste de président et directeur scientifique de Beam Therapeutics, Inc. Il est également membre de l'Infectious Diseases Society of America et de l'American Society of Gene Therapy. Dans le passé, le Dr Ciaramella a occupé les postes de directeur scientifique pour les maladies infectieuses chez Moderna, Inc, de responsable des produits biothérapeutiques, des antiviraux et de la découverte de nouveaux produits chez Pfizer Group Ltd et de vice-président et responsable de la recherche collaborative chez Boehringer Ingelheim Corp. Giuseppe Ciaramella a obtenu un doctorat de l'University College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC.
0,21% | 03/04/2024 | 169 616 ( 0,21% ) | 6 M $ | 31/03/2024 |
Postes actifs de Giuseppe Ciaramella
| Sociétés | Poste | Début |
|---|---|---|
| BEAM THERAPEUTICS INC. | President | 24/01/2020 |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Corporate Officer/Principal | - |
| American Society of Gene Therapy | Corporate Officer/Principal | - |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Founder | - |
Anciens postes connus de Giuseppe Ciaramella
| Sociétés | Poste | Fin |
|---|---|---|
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 01/02/2018 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Director/Board Member | 01/01/2014 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01/01/2011 |
Pfizer Group Ltd.
 Pfizer Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Group Ltd. is a British company that manufactures and sells pharmaceuticals, animal health products, and healthcare products. The private company is based in Sandwich, UK. | Corporate Officer/Principal | - |
Formation de Giuseppe Ciaramella
| University College London | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BEAM THERAPEUTICS INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Pfizer Group Ltd.
Pfizer Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Group Ltd. is a British company that manufactures and sells pharmaceuticals, animal health products, and healthcare products. The private company is based in Sandwich, UK. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
| American Society of Gene Therapy | |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Health Technology |
